4.7 Article

MicroRNA Profiling Reveals Distinct Profiles for Tissue-Derived and Cultured Endothelial Cells

Journal

SCIENTIFIC REPORTS
Volume 7, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-017-11487-4

Keywords

-

Funding

  1. Antti and Tyyne Soininen Foundation
  2. Kuopio University Foundation
  3. Maud Kuistila Memorial Foundation
  4. Academy of Finland
  5. Jane and Aatos Erkko Fondation
  6. Sigrid Juselius Foundation

Ask authors/readers for more resources

Endothelial plasticity enables the cells to switch their phenotype according to the surrounding vascular microenvironment. MicroRNAs (miRNAs) are small noncoding RNAs that control endothelial plasticity. The objective of this study was to investigate the differences in miRNA profiles of tissue-derived cells and cultured endothelial cells. To this end, miRNA expression was profiled from freshly isolated tissue-derived human vascular endothelial cells and endothelial cells cultured until cellular senescence using miRNA sequencing. In addition, the data was searched for putative novel endothelial miRNAs and miRNA isoforms. The data analysis revealed a striking change in endothelial miRNA profile as the cells adapted from tissue to cell culture environment and the overall miRNA expression decreased significantly in cultured compared to tissue-derived endothelial cells. In addition to changes in mechanosensitive miRNA expression, alterations in senescence-associated and endothelial-to-mesenchymal-transition-associated miRNAs were observed in aging cells. Collectively, the data illustrates the adaptability of endothelial cell miRNA expression that mirrors prevailing cellular environment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

NF-E2-related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin-1 mutated Alzheimer's disease astrocytes

Minna Oksanen, Ida Hyotylainen, Kalevi Trontti, Taisia Rolova, Sara Wojciechowski, Marja Koskuvi, Matti Viitanen, Anna-Liisa Levonen, Iiris Hovatta, Laurent Roybon, Sarka Lehtonen, Katja M. Kanninen, Riikka H. Hamalainen, Jari Koistinaho

Article Biochemistry & Molecular Biology

HAS3-induced extracellular vesicles from melanoma cells stimulate IHH mediated c-Myc upregulation via the hedgehog signaling pathway in target cells

Uma Thanigai Arasu, Ashik Jawahar Deen, Sanna Pasonen-Seppanen, Sami Heikkinen, Maciej Lalowski, Riikka Karna, Kai Harkonen, Petri Makinen, Elisa Lazaro-Ibanez, Pia R-M Siljander, Sanna Oikari, Anna-Liisa Levonen, Kirsi Rilla

CELLULAR AND MOLECULAR LIFE SCIENCES (2020)

Article Biochemistry & Molecular Biology

The EDCMET Project: Metabolic Effects of Endocrine Disruptors

Jenni Kublbeck, Taina Vuorio, Jonna Niskanen, Vittorio Fortino, Albert Braeuning, Khaled Abass, Arja Rautio, Jukka Hakkola, Paavo Honkakoski, Anna-Liisa Levonen

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cardiac & Cardiovascular Systems

NRF2 is a key regulator of endothelial microRNA expression under proatherogenic stimuli

Suvi Linna-Kuosmanen, Vanesa Tomas Bosch, Pierre R. Moreau, Maria Bouvy-Liivrand, Henri Niskanen, Emilia Kansanen, Annukka Kivela, Juha Hartikainen, Mikko Hippelainen, Hannu Kokki, Pasi Tavi, Anna-Liisa Levonen, Minna U. Kaikkonen

Summary: This study investigated the genome-wide effects of oxidized phospholipids on transcriptional gene regulation in endothelial cells, focusing on the role of miRNAs and NRF2 transcription factor. The results showed that NRF2 plays a key role in up-regulated transcripts and transcriptional initiation in response to oxidized phospholipids. Furthermore, NRF2 was identified as a novel regulator of over 100 endothelial pri-miRNAs, with miR-21-5p and miR-100-5p demonstrating opposing roles in gene expressions and potential correlation with the severity of coronary artery disease.

CARDIOVASCULAR RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis Insight From Mouse Models

Lidia Cedo, Jari Metso, David Santos, Annabel Garcia-Leon, Nuria Plana, Sonia Sabate-Soler, Noemi Rotllan, Andrea Rivas-Urbina, Karen A. Mendez-Lara, Mireia Tondo, Josefa Girona, Josep Julve, Victor Pallares, Aleyda Benitez-Amaro, Vicenta Llorente-Cortes, Antonio Perez, Diego Gomez-Coronado, Anna-Kaisa Ruotsalainen, Anna-Liisa Levonen, Jose Luis Sanchez-Quesada, Luis Masana, Petri T. Kovanen, Matti Jauhiainen, Miriam Lee-Rueckert, Francisco Blanco-Vaca, Joan Carles Escola-Gil

CIRCULATION RESEARCH (2020)

Article Genetics & Heredity

Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease

Ilakya Selvarajan, Anu Toropainen, Kristina M. Garske, Maykel Lopez Rodriguez, Arthur Ko, Zong Miao, Dorota Kaminska, Kadri Ounap, Tiit Ord, Aarthi Ravindran, Oscar H. Liu, Pierre R. Moreau, Ashik Jawahar Deen, Ville Mannisto, Calvin Pan, Anna-Liisa Levonen, Aldons J. Lusis, Sami Heikkinen, Casey E. Romanoski, Jussi Pihlajamaki, Paivi Pajukanta, Minna U. Kaikkonen

Summary: Genetic factors underlying coronary artery disease (CAD) have been extensively studied using genome-wide association studies (GWAS). This study identified potential target genes related to liver function by analyzing the function of non-coding single-nucleotide polymorphisms in CAD GWAS loci located within liver-specific enhancer elements. Furthermore, the analysis identified a significant number of unique SNPs with allele-specific regulatory activity, particularly enhancers near key genes involved in cholesterol homeostasis.

AMERICAN JOURNAL OF HUMAN GENETICS (2021)

Article Hematology

Profiling of Primary and Mature miRNA Expression in Atherosclerosis-Associated Cell Types

Pierre R. Moreau, Vanesa Tomas Bosch, Maria Bouvy-Liivrand, Kadri Ounap, Tiit Ord, Heidi H. Pulkkinen, Petri Polonen, Merja Heinaniemi, Seppo Yla-Herttuala, Johanna P. Laakkonen, Suvi Linna-Kuosmanen, Minna U. Kaikkonen

Summary: This study aimed to characterize microRNA-related regulatory mechanisms in the aorta during atherosclerosis. The research analyzed miRNA expression changes in different cell types under proatherogenic stimuli and found common miRNA species dominating in all cell types. The study identified potential mechanisms by which miRNAs affect atherogenesis in a cell-type-specific manner.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Article Environmental Sciences

A toxicogenomic data space for system-level understanding and prediction of EDC-induced toxicity

A. Sakhteman, M. Failli, J. Kublbeck, A. L. Levonen, V. Fortino

Summary: The study developed predictive models based on gene expression data to efficiently identify and prioritize EDCs, revealing key metabolic pathways and genes affected by EDCs.

ENVIRONMENT INTERNATIONAL (2021)

Article Oncology

A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase

Miika Mehine, Terhi Ahvenainen, Sara Khamaiseh, Jouni Harkonen, Siiri Reinikka, Tuomas Heikkinen, Anna Ayravainen, Paivi Pakarinen, Paivi Harkki, Annukka Pasanen, Anna-Liisa Levonen, Ralf Butzow, Pia Vahteristo

Summary: A novel subtype of uterine leiomyomas has been identified, characterized by distinct molecular features, mutations disrupting neddylation of the Cullin 3-RING E3 ligase, and activation of the NRF2 pathway. These findings provide new opportunities for targeted treatment of uterine leiomyomas.

ONCOGENESIS (2022)

Article Oncology

PI3Kβ inhibition enhances ALK-inhibitor sensitivity in ALK-rearranged lung cancer

Sarang S. Talwelkar, Mikko I. Mayranpaa, Julia Schuler, Nora Linnavirta, Annabrita Hemmes, Simone Adinolfi, Matti Kankainen, Wolfgang Sommergruber, Anna-Liisa Levonen, Jari Rasanen, Aija Knuuttila, Emmy W. Verschuren, Krister Wennerberg

Summary: Treatment with ALK inhibitors improves outcome for NSCLC patients with ALK-rearranged tumors, but resistance typically develops. In this study, tumor cell cultures were generated from an ALK-rearranged tumor specimen and drug screens identified a role for PI3K beta and EGFR inhibition in enhancing ALK-inhibitor response and preventing resistance. Combinatorial treatment with ALK and PI3K beta inhibitors showed promise in targeting ALK-rearranged NSCLC.

MOLECULAR ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies

Jouni Harkonen, Petri Polonen, Ashik Jawahar Deen, Ilakya Selvarajan, Hanna-Riikka Teppo, Elitsa Y. Dimova, Thomas Kietzmann, Maarit Ahtiainen, Juha P. Vayrynen, Sara A. Vayrynen, Hanna Elomaa, Niko Tynkkynen, Tiia Eklund, Teijo Kuopio, Eva-Maria Talvitie, Pekka Taimen, Markku Kallajoki, Minna U. Kaikkonen, Merja Heinaniemi, Anna-Liisa Levonen

Summary: The NRF2 pathway is frequently activated in various cancer types, but a comprehensive analysis of its effects across different malignancies is currently lacking. We developed a NRF2 activity metric and conducted a pan-cancer analysis of oncogenic NRF2 signaling using it. Our findings revealed an immunoevasive phenotype in squamous malignancies of the lung, head and neck area, cervix, and esophagus, where high NRF2 activity is associated with low interferon-gamma (IFNγ), HLA-I expression, and T cell and macrophage infiltration. These tumors have a molecular phenotype with amplification of SOX2/TP63, TP53 mutation, and CDKN2A loss, and are associated with upregulation of immunomodulatory genes NAMPT, WNT5A, SPP1, SLC7A11, SLC2A1, and PD-L1. Our functional genomics analyses suggest that these genes are candidate NRF2 targets, indicating a direct modulation of the tumor immune milieu. Single-cell mRNA data shows that cancer cells of this subtype exhibit decreased expression of IFNγ responsive ligands and increased expression of immunosuppressive ligands NAMPT, SPP1, and WNT5A involved in intercellular crosstalk. Moreover, the negative relationship between NRF2 and immune cells is explained by stromal populations of lung squamous cell carcinoma, indicating a potential effect across multiple squamous malignancies based on our molecular subtyping and deconvolution data.

REDOX BIOLOGY (2023)

Article Biochemistry & Molecular Biology

The KEAP1-NRF2 pathway: Targets for therapy and role in cancer

Simone Adinolfi, Tommi Patinen, Ashik Jawahar Deen, Sini Pitkänen, Jouni Härkönen, Emilia Kansanen, Jenni Küblbeck, Anna-Liisa Levonen

Summary: The KEAP1-NRF2 pathway is a crucial regulator of cellular defense against oxidative and electrophilic stimuli, playing a significant role in various disease pathologies. Research focused on understanding NRF2 signaling and its downstream effects has led to the identification of novel therapeutic targets. This graphical review provides an updated overview of the KEAP1-NRF2 signaling, highlighting recent advancements in the field, including the mechanism of NRF2 activation and its potential application in cancer diagnostics and treatment.

REDOX BIOLOGY (2023)

No Data Available